Nice numbers [Regulatives / Guidelines]

posted by Beholder  – Russia, 2018-06-22 10:33 (1265 d 01:59 ago) – Posting: # 18946
Views: 7,003

Hi, Helmut!

» We find nice numbers which are “easy to remember” everywhere.

Thx a lot for clarification.

Im just comparing the EU legislation and EEU legislation because it is very similar. May be you or other members of the forum know how can one understand whether we need to perform BEQ study in case of changes in amount of tablets in production batch or not? I refer to the table B.II.b.4 Change in the batch size (including batch size ranges) of the finished product which says (point c):
c) The change requires assessment of the comparability of a biological/immunological medicinal product or the change in batch size requires a new bioequivalence study
(my emphasis)

Best regards
Beholder

Complete thread:

Activity
 Admin contact
21,788 posts in 4,557 threads, 1,548 registered users;
online 10 (0 registered, 10 guests [including 6 identified bots]).
Forum time: Wednesday 11:32 CET (Europe/Vienna)

There is no adequate defense, except stupidity,
against the impact of a new idea.    Percy Williams Bridgman

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5